China's Tian Ruixiang Bets Big On Health Insurance AI With Ucare Acquisition
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 30 2025
0mins
Source: Benzinga
Acquisition Announcement: Tian Ruixiang Holdings Ltd. (TIRX) is acquiring Ucare Inc. for $150 million in an all-share deal to strengthen its position in China's health insurance market, with the transaction expected to close by July 2025.
Ucare's AI Platform Benefits: Ucare operates a cloud-based, AI-powered platform that aids hospitals and insurers in reducing fraud and costs, having saved nearly $7 billion in healthcare expenses, while also aiming to meet a revenue target of 150 million Chinese Yuan within three years post-acquisition.
Analyst Views on TIRX
About TIRX
Tian Ruixiang Holdings Ltd is a holding company primarily engaged in the provision of insurance brokerage services. The Company is engaged in the distribution of two categories of insurance products including property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance and automobile insurance, and other types of insurance, such as health insurance, life insurance, and miscellaneous insurance. The Company markets and promotes products and services through offline outlets, online platforms, and cross-industry collaborations. The Company sells insurance products to both individual and institutional customers. The Company mainly conducts its businesses within domestic market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
